Searched over 200M research papers
10 papers analyzed
These studies suggest that high triglycerides, even with normal cholesterol, are associated with increased risks of coronary artery disease, cardiovascular disease, and mortality, particularly when combined with low HDL cholesterol or insulin resistance.
20 papers analyzed
High triglycerides with normal cholesterol levels can present a unique cardiovascular risk profile. Triglycerides are a type of fat found in the blood, and their elevation is often associated with various metabolic conditions. While cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, are commonly monitored to assess cardiovascular risk, high triglycerides can independently contribute to heart disease, even when cholesterol levels are within normal ranges.
Research from the Framingham Heart Study indicates that individuals with high triglycerides and low high-density lipoprotein (HDL) cholesterol levels are at a significantly higher risk of developing coronary artery disease (CAD). This risk persists independently of other major risk factors, including low HDL cholesterol. The study highlights that this lipid profile is prevalent and contributes to a substantial number of CAD cases.
Elevated triglycerides are a significant independent risk factor for coronary heart disease, particularly in women and men with low HDL cholesterol levels. The total cholesterol/HDL cholesterol ratio is a critical indicator of CHD risk, and individuals with high triglycerides often have a high ratio, further increasing their risk.
A 22-year follow-up study of patients with established coronary heart disease found that higher triglyceride levels are independently associated with increased all-cause mortality. Even moderate elevations in triglycerides (100-149 mg/dL) were linked to a higher risk of death compared to lower levels, underscoring the importance of managing triglyceride levels.
High triglyceride levels are closely associated with insulin resistance and hyperinsulinemia. A study in normal-weight healthy adults found that a high triglyceride/HDL cholesterol ratio is a strong predictor of insulin resistance and hyperinsulinemia after an oral glucose tolerance test. This suggests that elevated triglycerides can be an early marker of metabolic dysfunction, even in the absence of obesity or diabetes.
In individuals with abnormal glucose metabolism, high triglycerides combined with high non-HDL cholesterol significantly increase the risk of cardiovascular disease. This combination is particularly detrimental, highlighting the need for comprehensive lipid management in patients with metabolic disorders.
The intra-individual variation in triglyceride levels can be substantial, ranging from 12.9% to 40.8% within a year. This variability can complicate the assessment and management of triglyceride levels, making it essential to consider multiple measurements over time to obtain an accurate picture.
While lowering triglycerides is a common therapeutic goal, it does not always lead to improvements in HDL cholesterol levels. For instance, dietary interventions that successfully reduced triglyceride levels in men with Type IV hyperlipoproteinemia did not result in increased HDL cholesterol levels, suggesting that low HDL may be an independent metabolic abnormality.
High triglycerides, even in the presence of normal cholesterol levels, pose significant cardiovascular and metabolic risks. They are associated with increased coronary heart disease, insulin resistance, and long-term mortality. Effective management requires a comprehensive approach that addresses both triglyceride levels and associated metabolic conditions. Regular monitoring and targeted interventions are crucial to mitigate the risks associated with this lipid profile.
Most relevant research papers on this topic